The present disclosure is directed to dermatological formulations and their use for treating a variety of dermatological diseases and disorders, and for repairing and restoring a disrupted epidermal barrier, inhibiting inflammation, restoring a proper environment for maintaining a balanced symbiotic microbiome, and inhibiting the growth of pathogenic microorganisms in the epidermis—the outer layer of mammalian skin.
本公开涉及用于治疗多种皮肤病和疾病的制剂及其用途,并用于修复和恢复受损的表皮屏障,抑制炎症,恢复适合保持平衡共生菌群的适当环境,以及抑制表皮(哺乳动物皮肤的外层)中病原微
生物的生长。